Genelabs Technologies Inc. (NASDAQ:GNLB) of Redwood City,Calif., has granted to Cellular Products Inc. of Buffalo, N.Y., co-exclusive marketing rights to distribute Western blot tests inNorth, Central and South America, the companies announced.
The agreement covers confirmatory Western blot assays forHIV-1, HIV-2, HTLV-I and HTLV-II, as well as the automatedequipment to run the tests, manufactured by Genelabs' partner,Diagnostic Biotechnology (Pte) Ltd. of Singapore.
Cellular Products will incorporate Genelabs tests into itsexisting product line consisting of AIDS and HTLV-I screeningassays and other biomedical products intended for basicresearch studies in the areas of cancer, AIDS, the humanimmune system and cell biology.
(c) 1997 American Health Consultants. All rights reserved.